FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017263886> ?p ?o ?g. }

• W2017263886 endingPage "78.e12" @default.
• W2017263886 startingPage "67" @default.
• W2017263886 abstract "Platinum-based chemotherapy regimens can cause DNA damage. Macrophage migration inhibitory factor (MIF) plays an important role in the regulation of the cell cycle by either controlling the activity of the SKP1-Cullin/Cdc53-F-box protein ubiquitin ligase (SCF) complex or activating its receptor, CD74.We used a pathway-based approach to investigate the association between genetic polymorphisms in MIF-pathway genes and the outcomes of platinum-based chemotherapy in advanced non-small-cell lung cancer (NSCLC). We used iSelect 24×1 HD BeadChip (Illumina, Inc, San Diego, CA) to genotype 32 tag and potentially functional single nucleotide polymorphisms (SNPs) of 8 selected genes and evaluated their associations with different outcomes for 1004 patients with advanced NSCLC treated with platinum-based chemotherapy. In particular, gastrointestinal toxicity and hematologic toxicity were analyzed for associations with specific genotypes, alleles, and haplotypes.Two polymorphisms of CD74, rs2748249 (C/A) and rs1560661 (A/G), were significantly associated with hematologic toxicity. Carrying an A allele in rs2748249 was associated with higher hematologic toxicity (odds ratio [OR], 1.72; 95% confidence interval [CI], 1.24-2.39; P = .001) and carrying a G allele in rs1560661 was associated with lower hematologic toxicity (OR, 0.42; 95% CI, 0.25-0.70; P = .00099) compared with the wild type. Haplotype analysis revealed that the patients with the CG haplotype (consisting of rs2748249 and rs1560661) had reduced hematologic toxicity compared with patients with other haplotypes (OR, 0.70; 95% CI, 0.56-0.87; P = .0013). The binding domain shared by 3 transcription factors (activator protein-2α [AP-2α], progesterone response A/B, and TFII-I) comprised the 2 SNPs that may be involved in the regulation of CD74-related B-cell survival.Our study is the first to suggest, to our knowledge, that polymorphisms in CD74 might be a marker of lower hematologic toxicity for patients with advanced NSCLC receiving platinum-based chemotherapy." @default.
• W2017263886 created "2016-06-24" @default.
• W2017263886 creator A5002040792 @default.
• W2017263886 creator A5006451847 @default.
• W2017263886 creator A5011592627 @default.
• W2017263886 creator A5022621937 @default.
• W2017263886 creator A5028624269 @default.
• W2017263886 creator A5042482515 @default.
• W2017263886 creator A5047615050 @default.
• W2017263886 creator A5048145081 @default.
• W2017263886 creator A5049692788 @default.
• W2017263886 creator A5051169949 @default.
• W2017263886 creator A5066429866 @default.
• W2017263886 creator A5071924811 @default.
• W2017263886 creator A5076749546 @default.
• W2017263886 creator A5077156454 @default.
• W2017263886 creator A5083902642 @default.
• W2017263886 date "2014-01-01" @default.
• W2017263886 modified "2023-10-01" @default.
• W2017263886 title "Novel Association Between CD74 Polymorphisms and Hematologic Toxicity in Patients With NSCLC After Platinum-Based Chemotherapy" @default.
• W2017263886 cites W1967780736 @default.
• W2017263886 cites W1971006828 @default.
• W2017263886 cites W1973993543 @default.
• W2017263886 cites W1981989535 @default.
• W2017263886 cites W1983562477 @default.
• W2017263886 cites W1984154122 @default.
• W2017263886 cites W1989832114 @default.
• W2017263886 cites W1990933325 @default.
• W2017263886 cites W1998323672 @default.
• W2017263886 cites W2004196173 @default.
• W2017263886 cites W2010140340 @default.
• W2017263886 cites W2012670711 @default.
• W2017263886 cites W2012874261 @default.
• W2017263886 cites W2020733688 @default.
• W2017263886 cites W2020830322 @default.
• W2017263886 cites W2023030470 @default.
• W2017263886 cites W2028178310 @default.
• W2017263886 cites W2029304297 @default.
• W2017263886 cites W2037139573 @default.
• W2017263886 cites W2042483817 @default.
• W2017263886 cites W2049239930 @default.
• W2017263886 cites W2054437145 @default.
• W2017263886 cites W2059072983 @default.
• W2017263886 cites W2085124463 @default.
• W2017263886 cites W2091781228 @default.
• W2017263886 cites W2106787323 @default.
• W2017263886 cites W2112280924 @default.
• W2017263886 cites W2113808060 @default.
• W2017263886 cites W2128840922 @default.
• W2017263886 cites W2138241344 @default.
• W2017263886 cites W2139248078 @default.
• W2017263886 cites W2140260672 @default.
• W2017263886 cites W2141032252 @default.
• W2017263886 cites W2153906296 @default.
• W2017263886 cites W2161048718 @default.
• W2017263886 cites W2315462659 @default.
• W2017263886 cites W3145077989 @default.
• W2017263886 doi "https://doi.org/10.1016/j.cllc.2013.08.006" @default.
• W2017263886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24220096" @default.
• W2017263886 hasPublicationYear "2014" @default.
• W2017263886 type Work @default.
• W2017263886 sameAs 2017263886 @default.
• W2017263886 citedByCount "3" @default.
• W2017263886 countsByYear W20172638862014 @default.
• W2017263886 countsByYear W20172638862015 @default.
• W2017263886 countsByYear W20172638862017 @default.
• W2017263886 crossrefType "journal-article" @default.
• W2017263886 hasAuthorship W2017263886A5002040792 @default.
• W2017263886 hasAuthorship W2017263886A5006451847 @default.
• W2017263886 hasAuthorship W2017263886A5011592627 @default.
• W2017263886 hasAuthorship W2017263886A5022621937 @default.
• W2017263886 hasAuthorship W2017263886A5028624269 @default.
• W2017263886 hasAuthorship W2017263886A5042482515 @default.
• W2017263886 hasAuthorship W2017263886A5047615050 @default.
• W2017263886 hasAuthorship W2017263886A5048145081 @default.
• W2017263886 hasAuthorship W2017263886A5049692788 @default.
• W2017263886 hasAuthorship W2017263886A5051169949 @default.
• W2017263886 hasAuthorship W2017263886A5066429866 @default.
• W2017263886 hasAuthorship W2017263886A5071924811 @default.
• W2017263886 hasAuthorship W2017263886A5076749546 @default.
• W2017263886 hasAuthorship W2017263886A5077156454 @default.
• W2017263886 hasAuthorship W2017263886A5083902642 @default.
• W2017263886 hasConcept C104317684 @default.
• W2017263886 hasConcept C126322002 @default.
• W2017263886 hasConcept C135763542 @default.
• W2017263886 hasConcept C143998085 @default.
• W2017263886 hasConcept C153209595 @default.
• W2017263886 hasConcept C156957248 @default.
• W2017263886 hasConcept C197754878 @default.
• W2017263886 hasConcept C2776256026 @default.
• W2017263886 hasConcept C54355233 @default.
• W2017263886 hasConcept C71924100 @default.
• W2017263886 hasConcept C86803240 @default.
• W2017263886 hasConcept C98274493 @default.
• W2017263886 hasConceptScore W2017263886C104317684 @default.
• W2017263886 hasConceptScore W2017263886C126322002 @default.
• W2017263886 hasConceptScore W2017263886C135763542 @default.
• W2017263886 hasConceptScore W2017263886C143998085 @default.

• next